January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...
The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback